ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Obesity-Related Insulin Resistance Indices and CKD Risk in Patients with Diabetes and Coronary Heart Disease: A Multicenter Cohort Analysis.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease (CKD) is primarily caused by diabetes, a condition frequently complicated by obesity and insulin resistance (IR)-factors that also promote the development of diabetes and coronary heart disease (CHD). Consequently, whether the obesity-related IR index independently increases CKD risk requires further exploration. Methods: A total of 7741 patients with coexisting diabetes and CHD from three centers were included in this study. Multivariable-adjusted Cox regression analyses were performed to investigate the associations between four obesity-related IR indices-weight-adjusted-waist index (WWI), triglyceride glucose-body mass index (TyG-BMI), TyG combined with waist circumference (TyG-WC), and metabolic score for visceral fat (METS-VF)-and the risk of CKD in patients with concomitant diabetes and CHD. Restricted cubic splines (RCS) were plotted to further explore potential threshold effects. The predictive ability and incremental predictive value of these indices were evaluated using receiver operating characteristic (ROC) curves, time-dependent ROC curves, decision curve analysis (DCA), and the C-index. Results: Obesity-related IR indices were closely associated with an increased risk of CKD in patients with diabetes and CHD, with evidence of threshold effects. Notably, the risk became particularly pronounced when WWI, TyG-BMI, TyG-WC, and METS-VF exceeded 11.2 cm/√kg, 245 kg/m Conclusion: Obesity-related IR indices are significantly associated with an increased risk of CKD in patients with diabetes and CHD. Notably, METS-VF, which reflects visceral obesity and IR, demonstrated the strongest predictive capacity among the indices. These findings may have important implications for CKD risk assessment and clinical intervention in this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.